WHEN WAS A NEGATIVE CLINICAL-TRIAL BIG ENOUGH - HOW MANY PATIENTS YOU NEEDED DEPENDS ON WHAT YOU FOUND

被引:178
作者
DETSKY, AS
SACKETT, DL
机构
[1] UNIV TORONTO,DEPT MED,TORONTO M5S 1A8,ONTARIO,CANADA
[2] MCMASTER UNIV,DEPT MED,HAMILTON L8S 4L8,ONTARIO,CANADA
[3] MCMASTER UNIV,DEPT BIOSTAT,HAMILTON L8S 4L8,ONTARIO,CANADA
[4] MCMASTER UNIV,DEPT CLIN EPIDEMIOL,HAMILTON L8S 4L8,ONTARIO,CANADA
关键词
D O I
10.1001/archinte.145.4.709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:709 / 712
页数:4
相关论文
共 6 条
[1]   SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J].
DUNNETT, CW ;
GENT, M .
BIOMETRICS, 1977, 33 (04) :593-602
[2]   IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS [J].
FREIMAN, JA ;
CHALMERS, TC ;
SMITH, H ;
KUEBLER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) :690-694
[3]  
HILL JD, 1978, LANCET, V1, P837
[4]  
SACKETT DL, 1975, LANCET, V1, P1205
[5]   SAMPLE-SIZE NOMOGRAMS FOR INTERPRETING NEGATIVE CLINICAL-STUDIES [J].
YOUNG, MJ ;
BRESNITZ, EA ;
STROM, BL .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (02) :248-251
[6]  
1981, CAN MED ASS J, V124, P1156